Integra LifeSciences Holdings Corporation

Equities

IART

US4579852082

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2024-06-18 EDT 5-day change 1st Jan Change
29 USD +0.35% Intraday chart for Integra LifeSciences Holdings Corporation -0.31% -33.41%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
KKR & Co, CrowdStrike, GoDaddy to Join S&P 500 Index on June 24 MT
Integra Lifesciences Holdings Insider Bought Shares Worth $1,499,979, According to a Recent SEC Filing MT
Integra Lifesciences Holdings Insider Bought Shares Worth $995,816, According to a Recent SEC Filing MT
Sector Update: Health Care Stocks Steady Pre-Bell Friday MT
Integra LifeSciences Holdings to Repurchase $50 Million in Shares MT
Transcript : Integra LifeSciences Holdings Corporation Presents at Bank of America Health Care Conference 2024, May-14-2024 01:40 PM
Truist Cuts Price Target on Integra LifeSciences Holdings to $25 From $37, Keeps Hold Rating MT
Wells Fargo Downgrades Integra LifeSciences Holdings to Equalweight From Overweight, Cuts Price Target to $25 From $45 MT
Oppenheimer Downgrades Integra LifeSciences Holdings to Perform From Outperform MT
Tranche Update on Integra LifeSciences Holdings Corporation's Equity Buyback Plan announced on July 27, 2023. CI
Integra LifeSciences Shares Drop to Record Low on Unexpected Loss, Boston Facility Audit Findings DJ
Transcript : Integra LifeSciences Holdings Corporation, Q1 2024 Earnings Call, May 06, 2024
Integra LifeSciences Q1 Adjusted Earnings, Revenue Fall; Updates 2024 Outlook MT
North American Morning Briefing : Stock Futures -2- DJ
Integra LifeSciences Holdings Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Reports Q1 Revenue $368.9M, vs. Street Est of $362M MT
Earnings Flash (IART) INTEGRA LIFESCIENCES HOLDINGS CORPORATION Posts Q1 EPS $0.55, vs. Street Est of $0.55 MT
Integra LifeSciences Holdings Corporation Updates Earnings Guidance for the Year 2024 CI
Integra LifeSciences Holdings Corporation Provides Revenue Guidance for the Second Quarter of 2024 CI
North American Morning Briefing : Focus Turns to -2- DJ
Citigroup Upgrades Integra LifeSciences to Neutral From Sell With $38 Price Target MT
Citigroup Upgrades Integra LifeSciences to Neutral From Sell, Price Target is $38 MT
Integra LifeSciences Completes Acquisition of Acclarent MT
Integra LifeSciences Holdings Corporation acquired 100% stake in Acclarent, Inc. from Ethicon US, LLC for $280 million. CI
Integra Lifesciences Launches Micromatrix Flex to Provide Convenient Access to Hard-To-Reach Areas in Complex Cases CI
Chart Integra LifeSciences Holdings Corporation
More charts
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
13
Last Close Price
29 USD
Average target price
34.2 USD
Spread / Average Target
+17.93%
Consensus
  1. Stock Market
  2. Equities
  3. IART Stock
  4. News Integra LifeSciences Holdings Corporation
  5. Integra LifeSciences Holdings to Repurchase $50 Million in Shares